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The primary role of the water-soluble vitamin B2 (riboflavin) in cell biology is
connected with its conversion into FMN and FAD, the cofactors of a large number of
dehydrogenases, oxidases and reductases involved in a broad spectrum of biological
activities, among which energetic metabolism and chromatin remodeling. Subcellular
localisation of FAD synthase (EC 2.7.7.2, FADS), the second enzyme in the FAD forming
pathway, is addressed here in HepG2 cells by confocal microscopy, in the frame of
its relationships with kinetics of FAD synthesis and delivery to client apo-flavoproteins.
FAD synthesis catalyzed by recombinant isoform 2 of FADS occurs via an ordered bi-bi
mechanism in which ATP binds prior to FMN, and pyrophosphate is released before FAD.
Spectrophotometric continuous assays of the reconstitution rate of apo-D-aminoacid
oxidase with its cofactor, allowed us to propose that besides its FAD synthesizing activity,
hFADS is able to operate as a FAD “chaperone.” The physical interaction between FAD
forming enzyme and its clients was further confirmed by dot blot and immunoprecipitation
experiments carried out testing as a client either a nuclear lysine-specific demethylase 1
(LSD1) or a mitochondrial dimethylglycine dehydrogenase (Me2GlyDH, EC 1.5.8.4). Both
enzymes carry out similar reactions of oxidative demethylation, in which tetrahydrofolate
is converted into 5,10-methylene-tetrahydrofolate. A direct transfer of the cofactor from
hFADS2 to apo-dimethyl glycine dehydrogenase was also demonstrated. Thus, FAD
synthesis and delivery to these enzymes are crucial processes for bioenergetics and
nutri-epigenetics of liver cells.
Keywords: FAD, FAD synthase, flavinylation, lysine specific demethylase 1, dimethylglycine dehydrogenase, rat,
nucleus, mitochondria, nutri-epigenetics
Introduction
The crucial role of the water soluble vitamin B2 or riboflavin (Rf) in cell metabolism is linked
to Rf conversion into the enzyme cofactors flavin mononucleotide (FMN) and flavin adenine
dinucleotide (FAD). In all the prokaryotic and eukaryotic cells the flavin cofactors ensure the func-
tionality of hundreds of different flavoenzymes having dehydrogenase, oxidase, monooxygenase or
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reductase activities, and playing crucial roles in bioenergetics,
photochemistry, bioluminescence, redox homeostasis, chromatin
remodeling, DNA repair, protein folding, apoptosis, along with
other physiologically relevant processes (Joosten and van Berkel,
2007). Thus, it is not surprising that deficiency of FAD-dependent
enzyme and/or impairment of flavin homeostasis in humans
and model animals have been linked to several diseases, such
as cancer, cardiovascular diseases, anemia, abnormal fetal devel-
opment, neuromuscular and neurological disorders (for rev. see
Barile et al., 2013 and Refs therein). Therefore, understanding the
membrane trafficking, homeostatic control, compartmentalisa-
tion, and turnover of Rf-derived flavin coenzymes within the cell
is crucial to clarify the mechanism underlying the generation and
maintenance of a normal cellular flavoproteome and of cellular
metabolism. Some remaining challenges in cellular homeostasis
of flavin cofactors and mitochondrial flavoprotein biogenesis will
be dealt on in this paper.
Mammals must obtain Rf from the diet and, to a lesser
extent, from intestinal microflora, whereas bacteria, protists,
fungi, plants, and some animals can synthesize Rf from GTP
and ribulose 5-P (Bacher et al., 2000). Dietary riboflavin is
taken up in the human gastrointestinal tract by recently iden-
tified transporters, namely riboflavin transporters 1 (hRFT1)
and 2 (hRFT2), that allow for vitamin concentration in the
plasma and in blood cells (Haack et al., 2012). A third mem-
ber of the Rf transporter family, namely riboflavin transporter
3 (hRFT3), is highly expressed in the brain (Yao et al., 2010;
Patel et al., 2012; Foley et al., 2014). Mutations in hRFT2 and
hRFT3 have been identified as in several individuals with a
rare neurological disorder named Brown-Vialetto-Van Laere syn-
drome (Haack et al., 2012; Nabokina et al., 2012; Srour et al.,
2014).
Once internalized in the cells, Rf conversion to cofactors
occurs in two obligatory and ubiquitous steps, as schematised in
Figure 1. The first enzyme of this pathway is riboflavin kinase
(RFK, ATP: riboflavin 5′ phosphotransferase, EC 2.7.1.26), which
transfers to Rf a phosphoryl group from ATP and forms FMN);
the second enzyme—namely FAD synthase or FMN adenylyl
transferase (EC 2.7.7.2, FADS or FMN-AT), previously known as
FAD synthetase—is the enzyme responsible for FMN adenylation
to FAD.
Compartmentalisation of flavin cofactor pools, generating the
organelle-specific flavoproteome remains a question far from
being elucidated and is sometimes a matter of debate (Lin et al.,
2009; Barile et al., 2013; Kim and Winge, 2013; Lienhart et al.,
2013). The main problem impairing an exhaustive comprehen-
sion of this issue derives from the necessity to coordinate FAD
formation activities with events of cofactor assembly to client
apo-proteins, that in eukaryotes occur mainly in mitochon-
dria, but also in other compartments (Tu et al., 2000; Thorpe
Abbreviations: Rf, riboflavin; RFK, riboflavin kinase; FADS, FAD synthase;
hFADS, human FAD synthase; hFADS1, human FAD synthase isoform 1; hFADS2,
human FAD synthase isoform 2; FLAD1, FAD synthase gene; D-AAO, D-
amino acid oxidase; LSD1, Lysine specific demethylase 1; Me2GlyDH, dimethyl-
glycine dehydrogenase; mtFSF, mitochondrial flavinylation stimulating factor; PPi,
pyrophosphate; LDH, lactate dehydrogenase.
et al., 2002; Joosten and van Berkel, 2007; Stojanovski et al.,
2008).
Subcellular localisation of FAD forming enzymes in mam-
malian, yeast and plant cells (Barile et al., 1993, 2000; Pallotta
et al., 1998; Giancaspero et al., 2009) has been recently addressed
at the molecular level (Bafunno et al., 2004; Torchetti et al., 2010;
Liuzzi et al., 2012). These studies demonstrated that mitochon-
dria possess their own FADS isoforms. In humans two different
isoforms of human FADS were characterized, that are the prod-
ucts of alternative splicing generated from the human FLAD1
gene (Brizio et al., 2006; Galluccio et al., 2007). Isoform 1 and
2 are located in mitochondria and cytosol, respectively (Torchetti
et al., 2010).
Moreover, a novel FADS localisation was found to be the
nucleus ofmammalian cells (Giancaspero et al., 2013). Additional
sub-cellular localisations for FADS cannot be ruled out, and they
could contribute to the maintenance of distinct flavin cofactor
pools in different cellular compartments. The existence of a FAD
forming pathway in the nucleus appears in line with the pro-
posal of a possible control of FAD availability on the activity of
the nuclear enzyme lysine-specific demethylase-1 (LSD1), which
carries out the demethylation of di- and mono-methyllysine 4 in
histone H3, an important epigenetic modification (Luka et al.,
2011, 2014; Hino et al., 2012).
A second series of questions about the cellular biochemistry
of Rf derived cofactors concerns the mechanism of release of
the newly-synthesized FAD to “client” flavoproteins (Torchetti
et al., 2011; Miccolis et al., 2014). All the recombinant FADSs
produced up to now exhibit the ability to bind FAD—the prod-
uct of their activity—tightly but not covalently (1 mol FAD: 1
mol monomer), thus eliciting a typical flavoprotein absorbance
spectrum, see Torchetti et al. (2011). Following SDS-PAGE the
purified proteins still retain flavin fluorescence on the dena-
turing gel (Torchetti et al., 2011). FAD release from FADS is
likely to be tightly controlled, and presumably requires well-
defined conditions, including a correct redox state (Miccolis
et al., 2014), the presence of an apo-protein accepting the cofac-
tor and—possibly—some accessory proteins as reported for inor-
ganic (Bonomi et al., 2008; Ye and Rouault, 2010) and organic
cofactors (Padovani and Banerjee, 2009) in some human pro-
teins. The hypothesis of a role of accessory/acceptor proteins in
FAD release is consistent with (and—to some extent—supported
by) the extremely low turnover number (kcat) measured for
the purified enzyme (Torchetti et al., 2011) as the isolated
protein.
Experiments described here are aimed at (i) confirming the
multiple sub-cellular localization of FADS in human cells; (ii)
investigating in some detail the FADS kinetics; (iii) addressing
the issue of FAD release to different “client” flavoprotein, dif-
fering in nature and strength of FAD linkage and sub-cellular
localization. In each case we aim at demonstrating that a direct
interaction between the FAD forming machinery and the client
flavoprotein occurs, and that a direct cofactor transfer from the
donor to the apo-protein acceptor occurs in a sort of “FAD-
chaperoning” action played by FADS per se, without a third reac-
tant. The involvement of additional factors in vivo—including
Hsp60 and Hsp10—is also discussed.
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FIGURE 1 | FMN and FAD synthesis from riboflavin and main biological functions of flavoenzymes in mammalian cells.
Materials and Methods
Materials
All chemicals were of analytical or highest available grade
and, unless otherwise stated, were obtained from Sigma-
Aldrich. Polyvinylidene difluoride (PVDF) Hybond-P, Chelating
Sepharose Fast Flow, and DEAE-Sephacel were from Amersham
Ge-Healthcare. Reagents for protein assay were from Bio-Rad.
Mouse anti-Hsp60 and Hsp-10monoclonal antibodies were from
Stressgen. Monoclonal mouse anti-LSD1 antibody was from
Santa Cruz Biotechnology. Monoclonal mouse anti-β-actin anti-
body was from Abcam. Peroxidase conjugated anti-rabbit and
anti-mouse IgG secondary antibodies were from Thermo Sci-
entific. Alkaline phosphatase conjugated anti-rabbit and anti-
mouse IgG secondary antibodies were from Sigma-Aldrich. Alexa
Fluor conjugated anti-rabbit or anti-mouse IgG secondary anti-
bodies were fromMolecular Probes.
Cell Immunofluorescence and Confocal
Microscopy
Immunofluorescence experiments were performed essentially as
described elsewhere (Bruni et al., 2012; Cardone et al., 2012).
Briefly, cells seeded on glass coverslips were fixed with 4%
formaldehyde for 20min and washed with PBS. After permeabi-
lization (0.1% Triton X-100 in PBS, 15min) and blocking (0.1%
gelatin in PBS, 1 h), cells were incubated with the specific anti-
FADS rabbit antiserum (1:200 dilution). Nuclei were counter-
stained with Hoechst 2µM33658. After washing, coverslips were
mounted on microscope slides and confocal images were cap-
tured with a Leica TCS SP5 confocal microscope (LeicaMicrosys-
tems, Mannheim) using a 63X (N.A. = 1.32) oil immersion
objective, a 100mW Argon laser (488 nm line) and a 50mW
diode (405 nm) as in (Gerbino et al., 2012). Confocal images were
analyzed using the software Fiji (Schindelin et al., 2012) as in
Tonazzi et al. (2013).
Purification of Recombinant hFADS2 and Rat
Me2GlyDHs
Purified recombinant 6His-hFADS2 was prepared as described in
Torchetti et al. (2011). Protein concentration and FAD/ protein
monomer ratio (i.e., the flavinylation level) were estimated by
absorbance spectra, as in Torchetti et al. (2011). Purified recom-
binant 6His-m-Me2GlyDH and 6His-p-Me2GlyDH were pre-
pared in both their apo- and holo-form essentially as described
in Brizio et al. (2004) and Brizio et al. (2008), respectively. The
flavinylation level of purified recombinant Me2GlyDH was esti-
mated by measuring the UV fluorescence of the SDS-PAGE
separated protein band, due to covalently bound FAD cofactor,
essentially as described in Brizio et al. (2004, 2008).
Kinetic Analysis of 6His-hFADS2
FAD synthesis rate was measured at 37◦C in 1mL of a standard
reaction medium consisting of 50mM Tris-HCl, 5mM MgCl2,
pH 7.5 in the presence of FMN and ATP added at the appro-
priate concentrations. The reaction was started with the addition
of 6His-hFADS2. FAD synthesis rate was determined by taking
advantage of the differential fluorimetric properties of FAD with
respect to FMN (Barile et al., 1997). Fluorescence time courses
(excitation at 450 nm and emission at 520 nm) were followed
in a LS50 Perkin–Elmer spectrofluorimeter. In each experiment,
FAD and FMN fluorescence were calibrated individually using
standard solutions whose concentration was calculated by using
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ε450nm = 12.2mM
−1·cm−1 for FMN and 11.3mM−1·cm−1 for
FAD. Under the experimental conditions used here, the FAD flu-
orescence constant (KFAD) was about 10 times lower than that
of FMN (KFMN). Thus, the rate of FAD synthesis, expressed as
nmol FADmin−1 (mg protein)−1, was calculated from the rate of
fluorescence decrease, measured as the tangent to the initial part
of the experimental curve by applying the equation described in
detail elsewhere (Torchetti et al., 2011).
Reconstitution of holo-DAAO Activity
The reconstituted holo-D-amino acid oxidase (D-AAO, EC
1.4.3.3) activity, derived from FAD binding to the apo-D-AAO,
was followed spectrophotometrically as described in Barile et al.
(2000), using 25mM D-alanine as substrate. NADH oxidation in
the L-lactate dehydrogenase (LDH, EC 1.1.1.27)-coupled reaction
was followed spectrophotometrically at 340 nm. The reaction rate
was calculated by measuring the slope of the tangent to the linear
part of the experimental curve. This rate was proven to be propor-
tional to FAD concentration. Calibration curves were obtained by
using standard FAD solutions.
Preparation of Pure Nuclei from Rat Liver
Nuclei were isolated from the liver of male Wistar rats by differ-
ential centrifugation in sucrose gradient essentially as in Gian-
caspero et al. (2013). The isolated nuclei were finally resuspended
in nuclear buffer (20mM Tris-HCl, pH 7.5, 0.5mM PMSF). The
purity and functionality of the nuclear fractions were checked as
in Giancaspero et al. (2013) by following (i) the increase in the
enzymatic activity of the nicotinamidemononucleotide adenylyl-
transferase, a central player NAD biosynthesis, mostly expressed
in the nucleus as isoenzyme 1 (Orsomando et al., 2012), (ii) the
decrease in the enzymatic activity of LDH amarker enzyme of the
cytosolic compartment. As a control immunoblotting assays of
lamin A/C (a nuclear marker) and of tubulin (a cytosolic marker)
were also carried out, as in Giancaspero et al. (2013).
Preparation of Mitochondrial Matrix from Rat
Liver and its Fractionation
The mitochondrial matrix was obtained from purified rat liver
mitochondria, as previously described (Barile et al., 1997) and
fractionated by ionic-exchange chromatography according to
Brizio et al. (2000) and Bafunno et al. (2004). Briefly, the
mitochondrial matrix (17.5mg/mL) was applied onto a DEAE-
Sephacel column (2 cm× 0.7 cm), equilibrated with 50mM Tris-
HCl, pH 7.5. The column was washed with the starting buffer
(1mL), then eluted with a discontinuous gradient of NaCl (50–
250mM, step 50mM) in the same buffer. For each step of
the gradient two fractions of 0.5mL were collected. Each chro-
matographic fraction was analyzed by western blotting using a
rabbit polyclonal antiserum directed against human FADS (anti-
FADS, International Application number PCT/IT2009/000062
filed February 23, 2009 by Barile, Torchetti, Indiveri, Galluccio),
as described in Brizio et al. (2013). Flavinylation Stimulating Fac-
tor (mtFSF) activity was assayed in each fraction here by measur-
ing the increase of the flavin fluorescence of Me2GlyDH protein
band separated by SDS-PAGE.
Immunoblotting
SDS-PAGE separated proteins were electro-transferred onto a
PVDF membrane using a Trans-Blot semidry electrophoretic
transfer cell (Sigma–Aldrich). The immobilized proteins were
incubated overnight with a 3000-fold dilution of anti-FADS
antiserum, as in Giancaspero et al. (2013). Other anti-
bodies were used to reveal and quantify protein markers,
including a mouse monoclonal anti-β-actin antibody (1:10,000
dilution), and mouse monoclonal antibodies: anti-LSD1 (1:1000
dilution); anti-Hsp60 (1:1000 dilution); anti-Hsp10 (1:1000
dilution). Bound antibodies were visualized with secondary
anti-rabbit or anti-mouse IgG antibodies conjugated with per-
oxidase (1:3500 dilution) or with alkaline phosphatase (1:3500
dilution).
Dot Blot Experiments
To identify the interaction between nuclear proteins and
hFADS2, purified rat liver nuclei (50 or 100µg) or purified
recombinant 6His-hFADS2 (5µg) were dot-blotted onto a nitro-
cellulose membrane. Where indicated, rat liver homogenate
(homo, 50 or 100µg), nuclei (50 or 100µg) or nuclear buffer
(none) were added to the dotted membrane. After 30min incu-
bation at 37◦C the membranes were washed, saturated in block-
ing solution containing BSA 3–5% and probed with antibodies
directed against human FADS (anti-FADS), LSD1 (anti-LSD1) or
actin (anti-ACT1). Following a washing step, the bound antibod-
ies were visualized with secondary anti-rabbit or anti-mouse IgG
antibodies conjugated with alkaline phosphatase (1:3500 dilu-
tion). To reveal the interaction betweenMe2GlyDH and hFADS2,
purified recombinant Me2GlyDH (1µg) was dotted onto a nitro-
cellulose membrane. Purified recombinant 6His-hFADS2 (3µg,
in HEPES buffer 40mM, pH 7.5, 5mMMgCl2) was added to the
dotted membrane in the presence of 5mM ATP and, where indi-
cated, of 20µMFMN.After 30min incubation at 37◦C, themem-
branes were washed and probed with the anti-FADS antiserum as
above.
Immunoprecipitation Experiments
Anti-FADS antiserum was added to a Dynabeads R© Protein G
immuno-precipitation kit according to manufacturer’s proce-
dure and used to immuno-precipitate purified rat liver nuclei
(50µg). The nuclear immuno-precipitated proteins were ana-
lyzed by immuno-blotting with the anti-FADS antiserum. The
same PVDF membrane was tested with the anti-LSD1 and anti-
ACT1 antibodies after performing a stripping procedure. The
bound antibodies were visualized with secondary anti-rabbit or
anti-mouse IgG antibodies conjugated with peroxidase (1:3500
dilution).
Other Assays
Protein concentration was assayed according to Bradford (1976),
using bovine serum albumin (BSA), as standard. Quantitative
evaluation of UVfluorescent and immuno-reactive protein bands
was carried out by densitometric analysis using the Image lab
software (BIORAD).
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Results and Discussion
Subcellular Localization of FADS in Human Liver
Carcinoma (HepG2) Cells
As stated in the Introduction, the first challenge of this paper
is to provide further evidence of multi-compartmentalisation
of FADS in human cells. The presence of FADS in both the
mitochondrion and nucleus was demonstrated for the first
time in freshly isolated rat liver fractions (Giancaspero et al.,
2013). To confirm the multi-compartmentalisation of FADS
in human cells, immunofluorescence experiments were carried
out on a human cell line derived from liver carcinoma, i.e.,
HepG2 (Figure 2). After fixation, permeabilization and incu-
bation with the anti-FADS antiserum the immuno-complexes
were visualized with a secondary antibody conjugated with
Alexa Fluor 488 (Figure 2A). After nuclei counterstaining with
Hoechst 33568 (Figure 2B), the coverslips were analyzed by con-
focal fluorescence microscopy. As apparent in Figures 2A,C,
besides the expected cytoplasmic localization, a clear FADS-
immunoreactivity was visible in the nucleus of HepG2 cells.
Steady State Kinetics of Recombinant FADS
Figure 3 reports the results of steady state kinetic experiments
carried out with the recombinant 6His-hFADS2, i.e., the cytoso-
lic form of the enzyme (Torchetti et al., 2010), and aimed at
addressing the second challenge, i.e., the enzyme mechanism of
the synthase.
The dependence of the rate of FAD formation on FMN con-
centration (from 0.1 to 2µM) at fixed concentrations of ATP was
investigated by means of a rapid spectrofluorimetric assay (Barile
et al., 1997). Results are reported according to a Linaeawever-
Burk plot (Figure 3A). The dependence of reaction rate on ATP
(ranging from 0 to 100µM) at fixed FMN concentrations was
investigated in parallel experiments (Figure 3B).
When FMN is varied at different ATP levels (from 1 to
100µM), the pattern intersects on the vertical axis (Figure 3A).
Thus, the KmFMN value decreases (from 8µM to 0.4µM) at
increasing ATP concentration. Conversely, when ATP is varied,
the patterns intersects in the forth quadrant (Figure 3B). Thus,
KmATP does not change significantly (at≈ 15µM) when increas-
ing FMN concentration. A replot of the slopes of the Lineawever-
Burk plot (with FMN as variable substrate) vs. 1/[ATP] has a
finite vertical intercept (inset of Figure 3A). A replot of the slopes
of the Lineawever-Burk plot (with ATP as variable substrate) vs.
1/[FMN] goes through the origin, instead of having a finite ver-
tical intercept. This patterns are consistent with a “sequential
ordered bi-bi” mechanism for 6-His-hFADS2, and allow to define
the order of substrate binding to the enzyme as ATP binding prior
to FMN.
To define the order of product release the inhibition patterns
of PPi, one of the products in the FADS reaction, were studied
according to a Dixon analysis (using fixed FMN concentration at
2µM in Figure 3C and using fixed ATP concentration at 10µM
in Figure 3D). In Figure 3C a non-competitive inhibition pat-
tern by PPi was observed when ATP is the variable substrate,
since the patterns intersect on the horizontal axis. In Figure 3D
the inhibition by PPi against FMN is consistent with competitive
inhibition, since the pattern intersects in the forth quadrant. This
mechanism is a special case of an ordered mechanism, named
as the Theorell-Chance (see The enzyme- Kinetics and mecha-
nism, Clealand, 1970). This allows to establish that PPi is the first
product released immediately after FMN binds to the enzyme.
The results in Figure 3 clearly indicate that FAD synthesis
occurs via an ordered bi-bi mechanism in which ATP binds prior
to FMN, and pyrophosphate is released before FAD. A similar
mechanism has been reported for other FADS, such as those from
rat (Oka and McCormick, 1987) and C. glabrata (Huerta et al.,
2009).
The slow release of FAD after PPi is consistent with (and to
some extent supported by) the extremely low turnover num-
ber (kcat) measured for the recombinant purified enzyme when
monitoring FAD synthesis by direct and indirect assays and the
observation that FAD remains tightly bound to the recombinant
purified enzyme (Torchetti et al., 2011). Thus, our data indicate
that FAD releasemay represent the rate-limiting step of the whole
catalytic cycle and that the processes leading to FAD synthesis
and delivery to client apoproteins may be tightly controlled by
factors others than FADS itself.
FIGURE 2 | Confocal microscopic analysis of hFADS subcellular
localization in human liver carcinoma (HepG2) cells.
Maximum-intensity projections of confocal laser scanning image stacks
of HepG2 cells labeled with the polyclonal anti-FADS antiserum
followed by incubation with an Alexa Fluor 488-conjugated anti-rabbit
antibody (green, A). Nuclei were stained with Hoechst 33658 (blue, B).
The overlay of the two images is represented in (C). Scale bar =
10µm.
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FIGURE 3 | Steady state kinetic analysis of FAD synthesis catalyzed
by hFADS2. FAD synthesis rate, catalyzed by 6His-hFADS2 (2µg, 35.4
pmoli), was measured by the initial rate of fluorescence decrease (λex at
450 nm, λem at 520 nm) at 37◦C in 50mM Tris-HCl, pH 7.5 in the presence
of 5mM MgCl2 and FMN and ATP at the reported concentrations. Where
indicated, sodium pyrophosphate was added at the indicated
concentrations. In (A) the initial rates represented by the Lineweaver–Burk
plot of 1/ν vs. 1/[FMN] at fixed ATP concentrations. In the inset the slope and
intercepts of the Linaeawever-Burk plot (with FMN as variable substrate) vs.
1/[ATP]. In (B) the initial rates represented by the Lineweaver–Burk plot of 1/ν
vs. 1/[ATP] at fixed FMN concentrations. In the inset the slope and intercepts
of the Linaeawever-Burk plot (with ATP as variable substrate) vs. 1/[FMN]. In
(C) the Dixon plot of the inhibition by pyrophosphate at ATP 10µM and FMN
0.3µM (•) or 2µM (◦). In (D) the Dixon plot of the inhibition by
pyrophosphate at FMN 2µM and ATP 10µM () or 50µM (). In (E) the
sequential ordered bi-bi mechanism for 6-His-hFADS2 is represented.
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The ability of the recombinant enzyme to catalyze FAD forma-
tion and delivery to a client apo-flavoprotein was next followed
by a continuous spectrophotometric assay in which newly syn-
thesized FAD is used to reactivate apo-D-AAO as a client flavo-
protein. The reconstituted activity of D-AAO on FAD incorpo-
ration is measured as the rate of NADH oxidation in a coupled
reaction with LDH (Figure 4A). Due to the time-dependence
of the reconstitution reaction (Casalin et al., 1991; Barile et al.,
2000), the reaction rate increases with time, reaching a maxi-
mum constant value, that was demonstrated to be proportional to
the amount of the externally added cofactor (Figure 4B). In the
experiment reported in Figure 4C, apo D-AAO was incubated in
the absence or presence of 1µg 6His-hFADS2 (which binds 1mol
per monomer of FADS tightly and that corresponds to 20 pmol
of the 56.5 kDa monomer and i.e., to 20 pmol of FAD bound to
6His-hFADS2) as well as in the presence of equimolar amount
of free FAD (20 pmol). The rate of absorbance decrease follow-
ing the addition of apo-D-AAO was equal to 0.0046 1A/min in
the absence of FAD addition (trace none). This rate is presumably
due to a small fraction of holo-enzyme present in the assay.When
20 pmol of FAD were added, the maximum value of the rate of
absorbance decrease was equal to 0.0069 1A/min, in agreement
with the occurrence of binding of FAD to apo-D-AAO. When
adding 1µg of 6His-hFADS to the assay, the rate of absorbance
loss increased with time, reaching a rate two-fold higher than
what measured with free FAD was added (1A/min = 0.0139).
These observations are consistent with the apo-holo transition
of DAAO being accelerated by 6His-hFADS. Therefore, FADS
seemed to operate not only as a synthase but also as a FAD
“chaperone, ” that is supposed to directly interact with the client
apo-flavoprotein during holoenzyme formation.
A further question was whether the expected physical inter-
action between FAD forming enzyme and its client could occur
also with apo-flavoproteins located both in the nucleus and in
the mitochondrion (Figure 5), where the enzyme could play a
primary role in cellular homeostasis. The occurrence of such
an interaction was previously hypothesized by different groups
(Barile et al., 2013; Brizio et al., 2013). To these scope, mitochon-
drial dimethylglycine dehydrogenase (Me2GlyDH, EC 1.5.8.4)
and nuclear lysine specific demethylase 1 (LSD1, EC 1.-.-.-) were
tested as client flavoproteins. Recombinant purified hFADS was
used to test the interaction with these client proteins by means
of dot-blot and immuno-precipitation experiments, and to ver-
ify transfer of the cofactor to the client apoprotein, wherever
possible.
LSD1 as a Client Flavoprotein
LSD1 is a nuclear FAD-containing amine oxidase, that cat-
alyzes the demethylation of mono- and dimethylated Lys4 on
histone H3, one of the most important recent discoveries in
FIGURE 4 | FAD delivery from 6His-hFADS2 to the client apo-D
amino acid oxidase. The release of FAD from the purified
recombinant 6His-hFADS2 to apo-DAAO was assayed enzymatically,
as described in Materials and Methods and schematized in (A), by
measuring the activity of reconstituted holo-DAAO (derived from FAD
binding to apo-DAAO). (B) Calibration curve obtained with a FAD
standard. In (C) typical traces are shown. Apo-DAAO was added in
the absence (none) or in the presence of purified 6His-hFADS2
(Holo-hFADS2, 1.2µg, 20 pmol) or in the presence of commercial
FAD (20 pmol) at 37◦C in 100µL of 50mM Tris-HCl, pH 7.5.
Reconstituted holo-DAAO activity was measured as described in
Materials and Methods.
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FIGURE 5 | Two client apo-flavoproteins: nuclear lysine specific
demethylase 1 (LSD1) and mitochondrial dimethylglycine
dehydrogenase (Me2GlyDH). LSD1 and Me2GlyDH are both FAD
containing enzyme which carry out similar reactions of oxidative
demethylation, assisted by tetrahydrofolate (H4Folate) used to form
5,10-methylene-tetrahydrofolate (5,10-CH2H4Folate).
nutri-epigenetics (Hino et al., 2012). During the course of the
reaction, FAD oxidizes the lysine N-methyl amine to lysine N-
methylimine, and FADH2 is reoxidized to FAD by molecular
oxygen producing hydrogen peroxide. In the absence of tetrahy-
drofolate, the oxidation of methyl groups generates formalde-
hyde, potentially highly toxic for the nucleus, that is expected to
be reduced and recycled to give S-adenosyl methionine (SAM),
the main nuclear methyl donor (Tyihak et al., 1998). Recently it
has been demonstrated that LSD1, as well as Me2GlyDH, is able
to bind tetrahydrofolate. Thus, both these reactions generate N-
5,10-methylene-tetrahydrofolate (Figure 5) in a sort of oxidative
demethylation of the substrates (Luka et al., 2011, 2014). There-
fore, nuclear pool of flavins and folates seems to be strictly inter-
connected in controlling the crucial processes of methylation
status of hystones and in nutri-epigenetics.
The LSD1 structure is well characterized. The protein consists
of a classical FAD-amino oxidase domain (IPR002937) where the
flavin cofactor is bound (not covalently). The folate-binding site
is located in the active center in close proximity to FAD. The
N-terminus contains a SWIRM domain (IPR007526), presum-
ably responsible for nucleosome recognition (Da et al., 2006) and
it is preceded by a disordered extension (Shi et al., 2004). Two
isoforms are reported in Entrez Gene for humans, as products
of alternative splicing of the KDM1A gene, the canonical iso-
form being a 852 residue long polypeptide (92.9 kDa). A sin-
gle rat isoform - corresponding to LSD1—is reported in Entrez
Gene, as a 872 residue long protein (Mr = 94.4 kDa) named
Kdm1a, exhibiting a similarity of 98% with respect to human
protein. Nevertheless, a wide BLAST search in non-redundant
protein sequence databases using as a query the canonical human
LSD1 isoform gave an additional product of 776 amino acids
(86.1 kDa), exhibiting a 99% identity with the human protein.
This isoform lacks of the first 96 aa respect to rat Kdm1a protein.
A prediction made with PSORTII program, gives a score of 11%
of nuclear localisation for Kdm1a and of 39% for the “similar to
AOF2 protein.” Kdm1a scores a 44% probability for an extracel-
lular localisation and a 22% probability for a cytosolic one. The
“similar to AOF2 protein” has a high probability to be cytosolic
(52%) and a very low probability to be localized in the mito-
chondrion (4%). No cleavage sites have been identified by this
bioinformatics approach.
In order to get some insight into LSD1 biogenesis, a nuclear
fraction was purified from rat liver homogenate, as previously
described (Giancaspero et al., 2013) and the enrichment in
specific nuclear protein assessed by measuring the increase
in the enzymatic activity of the nuclear enzyme nicotinamide
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mononucleotide adenylyltransferase, as described under Materi-
als and Methods.
First of all, the existence of FADS in the nucleus was revealed
by dot-blot, using a polyclonal antiserum against hFADS (anti-
FADS) and increasing amount of nuclear protein (50 or 100µg)
(Figure 6A). In parallel runs, dotted nuclear proteins were tested
for the presence of LSD1 by using a commercial monoclonal anti-
body. The identity of the nuclear fraction was further validated
by observing the enrichment of the nuclear protein LSD1 with
respect to the spots obtained when 50 or 100µg of homogenate
were added as a control (data not shown).
In order to investigate if the natural nuclear LSD1 protein
is able to directly interact with FADS, in a parallel experiments
5µg of recombinant human 6His-hFADS2 were dotted on the
membranes, and successful dotting was tested by using the anti-
FADS antiserum. FADS-dotted membranes were washed and
incubated for 15min with nuclear proteins, and the amount
of nuclear LSD1 bound to 6His-hFADS in the dots measured
immunochemically in comparison with the amount of protein
bound when starting from the homogenate. No 6His-hFADS2
was present in controls, and the specificity of 6His-hFADS2
/LSD1 interaction was tested by verifying the absence of actin
bound to the 6His-hFADS dotted membrane (Figure 6A).
To further validate the specificity of 6His-hFADS2/ LSD1
interaction, immuno-precipitation experiments were performed
and reported in Figure 6B. Following over-night incubation
(according to the manufacturer-suggested procedure, see below),
different anti-FADS cross-reactive bands were found in subse-
quent electrophoretic analysis of the products. The most evident
band was found at about 38 kDa, likely being a hydrolysis prod-
uct (see also Giancaspero et al., 2013). In the same fractions, after
stripping procedure, an anti-LSD1 reactive band migrating at
97 kDa was revealed (in good agreement with the molecular mass
of the kdm1a isoform) accompanied by a lower migrating band
(apparently a hydrolysis product of about 58 kDa). The 97 kDa
band appeared significantly enriched in the nuclear fraction.
Purified nuclear fractions were, then, immuno-precipitated by
using the anti-FADS antiserum and the immuno-precipitation kit
FIGURE 6 | FADS/LSD1 interaction as revealed by immunological
techniques. In (A) the dot-blot assay is reported: briefly, purified rat liver
nuclei (pNcl, 50 or 100µg) resuspended in the nuclear buffer or
6His-hFADS2 (5µg) were dotted onto a nitrocellulose membrane. Where
indicated pNcl (50 or 100µg), homogenate (homo, 50 or 100µg) or the
nuclear buffer (none) were added to the dotted membrane. Protein/protein
interaction was revealed immunochmically as described in Materials and
Methods. In (B) rat liver homogenate (homo, 25µg), nuclei (pNcl, 25µg) and
the immunoprecipitate (IPanti−FADS) from nuclear proteins (50µg) were
analyzed by immunoblotting with anti-FADS antiserum, as described in
Materials and Methods. The same PVDF membrane was analyzed with the
anti-LSD1 and anti-ACT1 antibodies after stripping procedure.
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Dynabeads Protein G. Immuno-precipitation resulted in a clear
enrichment of the three main anti-FADS cross reacting bands
located in the 65–56 kDa range, as expected from the predicted
molecular mass of rat FADSs (Giancaspero et al., 2013). The same
fraction was also revealed by using the anti-LSD1 antibody. Dif-
ferent cross reactive bands were immune-precipitated together
with FADS, and one of these bandsmigrates at about 80 kDa. ESI-
MS/MS analysis will be performed to identify whether the 80 kDa
band is a hydrolytic product of kdm1a or rather the protein sim-
ilar to AOF2. Thus, the emerging picture favors the proposal of a
physical interaction between the nuclear apo-flavoprotein LSD1
and FADS, an interaction of high relevance for attachment of a
FAD cofactor during enzyme biogenesis.
Me2GlyDH as a Client Flavoprotein
The mechanism of flavoprotein biogenesis is of particular rele-
vance in mitochondria, since they are the main site of localisation
of flavoenzymes bearing both covalently-bound FAD and non-
covalently bound FAD or FMN (Heikal, 2010; Barile et al., 2013;
Lienhart et al., 2013). As far as the mitochondrial flavoproteome
is concerned we focused our attention on Me2GlyDH, a key
enzyme of folate one-carbon metabolism and choline catabolism
(Figure 5), located in the mitochondrial matrix. In the presence
of tetrahydrofolate (THF), Me2GlyDH catalyzes the oxidative
demethylation of dimethylglycine to yield sarcosine and 5,10-
methylene-THF. In the natural mature Me2GlyDH the FAD
cofactor is covalently linked to the enzyme via a histidyl(N3)-(8α)
FAD linkage occurring at His84 (Cook et al., 1985). Me2GlyDH
is synthesized in the cytosol as a precursor protein containing an
N-terminal extra-sequence, which is removed in the organelle by
the mitochondrial processing peptidase (MPP) (Otto et al., 1996).
The flavin attachment event in vivo occurs in mitochondria
before removal of the pre-sequence (Brizio et al., 2002).
Both the mature (mMe2GlyDH) and the precursor
(pMe2GlyDH) forms of rat Me2GlyDH were produced in
Escherichia coli as, respectively, a N-terminally and C-terminally
6-His-tagged fusion protein (Brizio et al., 2004, 2008). Flavinyla-
tion of the in vitro synthesized apo-Me2GlyDH protein seemed
FIGURE 7 | Evidences of Me2GlyDH flavinylation and
identification of possible interactors. In (A) 6His-apo-Me2GlyDH
(10µg) was incubated at 37◦C in flavinylation medium made of
50mM Tris-HCl, pH 7.5, 5mM MgCl2 5mM, 0.5% Triton X-100,
5mM ATP, in the absence or presence of 20µM FAD. Where
indicated rat liver mitochondrial matrix (MX) (lane 4) or MX fractions
eluted onto a DEAE-Sephacel column with 50 and 200mM NaCl
(D50 and D200 fractions, 100µg each, lanes 6 and 8, respectively)
were added to the reaction mixture. As a control the same matrix
and DEAE fractions were incubated in the same experimental
condition in the absence of apo-Me2GlyDH and in the presence of
20µM FAD (lanes 3, 5, 7). After 1 h incubation, each sample was
passed on a Ni-Chelating Sepharose to re-isolate the recombinant
6His-apo-Me2GlyDH and possible interactors. After washing with
50mM imidazole, bound 6His-apo-Me2GlyDH and its possible
interactors were eluted with 500mM imidazole, precipitated with
acetone, and analyzed by SDS-PAGE. The flavin fluorescence of
SDS-PAGE separated proteins was visualized by UV irradiation of the
unstained gel soaked in 10% acetic acid. Protein bands were then
stained with Coomassie Brilliant Blue. The interactors were searched
for by immunoblotting analysis carried out using anti Hsp60 and
Hsp10 antibodies. The flavinylation level of Me2GlyDH (inset) was
estimated through image analysis as described in Materials and
Methods. In (B) matrix and fractions D50 and D200 (100µg each,
lanes 9–11) from ion-exchange chromatography were analyzed by
SDS-PAGE and immunoblotting as described in (A).
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FIGURE 8 | Evidences of physical interaction and cofactor release from
hFADS to the client Me2GlyDH. In (A) purified either precursor (p) or mature
(m) form of apo- and holo-Me2GlyDHs (1µg each) were dotted onto a
nitrocellulose membrane and incubated with purified recombinant human
6His-FADS2 in the presence of 5mM ATP and 5mM MgCl2. Where indicated
20µM FMN was added. After 30min incubation at 37◦C the membrane was
washed and probed with an anti-hFADS antiserum. In (B) purified recombinant
apo-pMe2GlyDH (1µg) was incubated at 37
◦C in the presence or absence of
recombinant 6His-hFADS2 (3.3µg) in 40mM Hepes buffer pH 7.4 containing
5mM ATP and 5mM MgCl2. FMN (20µM) was added where indicated. As a
control, 6His-hFADS2 (3.3µg) was incubated in the same conditions, but in
the absence of apo-pMe2GlyDH. After 30min incubation, protein were
denatured with the addition of sample buffer, boiled at 95◦C and analyzed by
SDS-PAGE. The flavin fluorescence of proteins was visualized by UV irradiation
of the unstained gel soaked in 10% acetic acid. Proteins were then stained
with Coomassie Brilliant Blue.
to proceed spontaneously in the presence of FAD, in line with
an autocatalytic process (Otto et al., 1996). Nevertheless, the
rate of Me2GlyDH holoenzyme formation was found to be
stimulated by protein factor(s) localized in mitochondrial
matrix, that were tentatively named mitochondrial flavinylation
stimulating factor(s) (mtFSF) (Brizio et al., 2000, 2002). mtFSF(s)
elutes at 50mM NaCl (DEAE50) following fractionation of the
mitochondrial matrix by ionic-exchange chromatography on a
DEAE-Sephacel column (Brizio et al., 2000, 2013).
A simple, rapid and directmethod for determining the flaviny-
lation level of the Me2GlyDH consists in revealing holoenzyme
flavin fluorescence upon irradiation with UV light of SDS-PAGE
gels provides (Brizio et al., 2004, 2008). Rat liver mitochon-
drial matrix gave two fluorescent native bands corresponding to
the two covalently flavinylated mitochondrial enzymes sarcosine
dehydrogenase and Me2GlyDH (Figure 7B, lane 9). The native
Me2GlyDH was eluted as a fluorescent band at 200mM NaCl
(DEAE200) following DEAE-Sephacel chromatography of mito-
chondrial matrix. Immunoblotting analysis of DEAE fractions
carried out with anti-Hsp60 antibodies revealed that Hsp60 was
mainly recovered in the DEAE200 fraction and was completely
absent in materials eluted at lower ionic strength (50mM NaCl,
DEAE50). This confirms that mtFSF differs from the matrix
chaperone Hsp60 (Brizio et al., 2000). Thus, a matrix component
other than Hsp60 might assist flavinylation of apo-Me2GlyDH.
Instead, we gathered immunoblotting evidence of the Hsp10 co-
chaperone being present in the DEAE50 fraction together with
the naturally occurring FADS (not shown).
In Figure 7A, to search for possible Me2GlyDH interac-
tors during flavinylation reaction, “re-binding” experiments
were performed Briefly, His-Me2GlyDH was re-isolated on Ni-
chelating Sepharose after a flavinylation step (Brizio et al.,
2013). UV fluorescence measurements (compare lanes 1–4,
and histogram in the inset) clearly confirm that mitochon-
drial matrix is able to stimulate apo-Me2GlyDH flavinyla-
tion (Brizio et al., 2013). This stimulation is observed with
the DEAE50 fraction, but not with the DEAE200 one. Both
the chaperone Hsp60 and the co-chaperone Hsp10 interact
with 6-His-Me2GlyDH, as revealed by immunoblotting anal-
ysis (Figure 7), therefore they both are expected to partici-
pate in the flavinylation machinery. Therefore, the finding that
the matrix flavinylation stimulating activity elutes in the same
chromatographic fraction that contains mtFADS (Brizio et al.,
2013), is prompting us to propose that—besides synthesiz-
ing the cofactor—FADS provide a chaperoning activity during
Me2GlyDH biogenesis.
To further demonstrate that recombinant hFADS physically
interacts with the Me2GlyDH client, protein-protein interac-
tion was analyzed by dot-blot experiments in which the purified
recombinant Me2GlyDH (1µg) was dotted onto the membrane
and incubated with purified recombinant human 6His-hFADS2
in the presence of ATP (5mM) and, when indicated, of FMN
(20µM). After 30min incubation at 37◦C the membrane was
washed and probed with an anti-hFADS antibody. These experi-
ments, reported in Figure 8A, indicated that FADS interacts with
both the precursor (pMe2GlyDH) and mature (mMe2GlyDH)
form of the acceptor protein.
To test whether direct transfer of FAD to the client pro-
tein, purified recombinant apo-pMe2GlyDHwas incubated in the
presence of ATP with purified recombinant hFADS, that binds
tightly 1 mol FAD/mol protein. After 30min incubation, pro-
teins were analyzed by SDS-PAGE, to follow holoenzyme forma-
tion. The unstained gel was analyzed to detect flavin fluorescence
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FIGURE 9 | The catalytic cycle of FAD synthesis and release by 6-His-hFADS2.
prior to protein staining. As shown in Figure 8B, hFADS loses its
fluorescence upon incubation with apo-Me2GlyDH while simul-
taneously promoting the flavinylation of apo-Me2GlyDH. The
yield in flavinylated Me2GlyDH increased when FMN was added
together with ATP.
Based on these and our previous results, we propose that mito-
chondrial FADS, besides synthesizing FAD, acts in mitochondria
as a “FAD chaperone” recognizing nascent apo-flavoproteins and
promoting their flavinylation.
Conclusion
Experiments described here confirmed the nuclear localization
of FADS in human cells and demonstrate a direct interaction
between the FAD formingmachinery and the nuclear client flavo-
protein LSD1, thus shading light on the possible role of flavin
cofactor homeostasis in epigenetic control.
Using the mitochondrial apo-flavoenzyme Me2GlyDH, we
observed a direct protein-protein interaction and the cofactor
transfer from the donor to the apo-protein acceptor, occurring in
a sort of “FAD-chaperoning” action played by hFADS per se. The
role of Hsp60/Hsp10 and a possible control exerted by the redox
status of the cofactor during its transfer from FADS to substrate
proteins is an interesting matter of future investigation.
The ordered bi-bi mechanism of FAD synthesis together with
the proposal of a flavinylation pathway involving hFADS are
presented in Figure 9.
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